Serum non‐transferrin‐bound iron in beta‐thalassaemia major patients treated with desferrioxamine and L1

British Journal of Haematology

Volumn 82, Issue 2, 1992, Pages 431-436

  Al Refaie F N ^a   Wickens, D G ^a,b   Wonke, B ^a   Kontoghiorghes, G J ^a   Hoffbrand, A V ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; FERRITIN; IRON; TRANSFERRIN;

ADULT; ANEMIA; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; FEMALE; HUMAN; IRON CHELATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; DEFEROXAMINE; FERRITIN; HUMAN; IRON; IRON CHELATING AGENTS; PATIENT COMPLIANCE; PYRIDONES; SUPPORT, NON-U.S. GOV'T; TRANSFERRIN;

EID: 0026646262     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1992.tb06441.x     Document Type: Article

References (24)

1. Non‐transferrin plasma iron in β‐thalassaemia/HbE and haemoglobin H disease
2. The kinetics and mechanism of iron (III) exchange between chelates and transferrin. I. The complexes of citrate and nitrilotriacetic acid
3. A non‐transferrin‐bound serum iron in idiopathic haemochromatosis
4. Tissue distribution and clearance kinetics of non‐transferrin‐bound iron in the hypotransferrinemic mouse: a rodent model for haemochromatosis
5. Hepatic iron deposition in humans. I. First‐pass hepatic deposition of intestinally absorbed iron in patients with low plasma latent iron‐binding capacity
6. A serum ferritin assay for prevalence studies of iron deficiency
7. Determination of DFX‐ available iron in biological tissues by high pressure liquid chromatography
8. Non‐transferin‐bound iron in plasma or serum from patients with idiopathic hemochromatosis
9. Iron complexes and their reactivity in the bleomycin assay for radical‐promoting looselybound iron
10. Low‐molecular‐weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis
11. Superoxide‐dependent formation of hydroxyl radicals in the presence of iron salts
12. Oxygen, free radicals and iron in relation to biology and medicine: some problems and concepts
13. Non‐transferrin plasma iron
14. Non‐specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity
15. Circulating levels of chelatable iron as a possible stimulator of free radical activity: a preliminary study in pulmonary tuberculosis
16. 1). I. Iron chelation and metabolic studies
17. Pharmacokinetic studies in humans with the oral iron chelator 1,2‐dimethyl‐3‐hydroxypyrid‐4‐one
18. Simple synthesis of the potent iron chelators 1‐alkyl‐3‐hydroxy‐2‐methylpyrid‐4‐ones
19. Quantitation of ferritin iron in plasma, an explanation for non‐transferrin iron
20. Quantification of non‐transferrin‐bound iron in thalassaemic plasma
21. A direct method for quantification of non‐transferrin‐bound iron
22. Ferrozine a new spectrophotometric reagent for iron
23. Free‐iron and iron toxicity in iron overload